| Pharmaceutical Information |
| Drug Name |
Mianserin |
| Drug ID |
BADD_D01454 |
| Description |
A tetracyclic compound with antidepressant effects. Mianserin was previously available internationally, however in most markets it has been phased out in favour of [mirtazapine]. |
| Indications and Usage |
For the treatment of depression. |
| Marketing Status |
approved; investigational |
| ATC Code |
N06AX03 |
| DrugBank ID |
DB06148
|
| KEGG ID |
D08216
|
| MeSH ID |
D008803
|
| PubChem ID |
4184
|
| TTD Drug ID |
D0R6RO
|
| NDC Product Code |
Not Available |
| UNII |
250PJI13LM
|
| Synonyms |
Mianserin | Mianserin Hydrochloride | Hydrochloride, Mianserin | Mianserin Monohydrochloride | Monohydrochloride, Mianserin | Tolvon | Lerivon | Org GB 94 |
|
| Chemical Information |
| Molecular Formula |
C18H20N2 |
| CAS Registry Number |
24219-97-4 |
| SMILES |
CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
